MORGAN STANLEY - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,630,012
+2.5%
94,003
+7.2%
0.00%
Q2 2023$1,589,540
-79.1%
87,723
-69.3%
0.00%
-100.0%
Q1 2023$7,593,342
+244.6%
285,464
+150.5%
0.00%
Q4 2022$2,203,233
-50.6%
113,980
-46.7%
0.00%
-100.0%
Q3 2022$4,464,000
+56.6%
213,693
-40.0%
0.00%
Q2 2022$2,850,000
+26.0%
356,039
+10.3%
0.00%
Q1 2022$2,262,000
-51.2%
322,764
-5.9%
0.00%
-100.0%
Q4 2021$4,632,000
+81.4%
343,120
+126.9%
0.00%
Q3 2021$2,554,000
+160.1%
151,245
+348.9%
0.00%
Q2 2021$982,000
+477.6%
33,695
+679.4%
0.00%
Q1 2021$170,000
-22.0%
4,323
-55.0%
0.00%
Q4 2020$218,000
-40.8%
9,607
-40.9%
0.00%
Q3 2020$368,000
+569.1%
16,256
+856.2%
0.00%
Q2 2020$55,0001,7000.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 1,839,160$35,550,96327.86%
TRV GP IV, LLC 2,132,867$41,228,31917.53%
CHI Advisors LLC 3,169,892$61,274,01216.32%
GREAT POINT PARTNERS LLC 1,322,870$25,571,0775.01%
VR Adviser, LLC 1,080,000$20,876,4003.52%
Redmile Group, LLC 3,878,599$74,973,3193.07%
Casdin Capital, LLC 1,675,000$32,377,7502.51%
Fernwood Investment Management, LLC 304,573$5,887,3962.44%
Cheyne Capital Management (UK) LLP 66,144$1,278,5642.23%
First Light Asset Management, LLC 1,057,881$20,448,8401.90%
View complete list of PLIANT THERAPEUTICS INC shareholders